Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof

US8816082B2 · kind B2 · utility

Assignee

• The Royal Institution for the Advancement of Learning/McGill University · CA

Inventors

• Youla S. Tsantrizos · Mont-Laurier, CA
• Joris De Schutter · Montréal, CA
• Yih-Shyan Lin · Kaohsiung, TW

Key dates

• Filing date: May 27, 2011
• Grant date: Aug 26, 2014
• Expiry date: May 27, 2031

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel compounds, compositions containing same and methods for inhibiting human farnesyl pyrophosphate synthase or for the treatment or prevention of disease conditions using said compounds;